Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCHW) Change in Inventory (2022 - 2026)

Envoy Medical recorded quarterly Change in Inventory of -$44000.0 in Q1 2026, up 64.8% quarter-over-quarter from -$125000.0 in Q4 2025, and up 40.54% year-over-year from -$31307.7 in Q1 2025.

Envoy Medical's Change in Inventory history runs 5 years deep, the most recent figure standing at -$44000.0 for Q1 2026.

  • In Q1 2026, Change in Inventory rose 40.54% year-over-year to -$44000.0; the TTM figure through Mar 2026 stood at -$96000.0 (down 157.83% YoY), while the FY2025 annual figure was -$126000.0, down 133.16% from the prior year.
  • Change in Inventory came in at -$44000.0 for Q1 2026 at Envoy Medical, up from -$125000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $300000.0 in Q2 2024 to a low of -$203000.0 in Q3 2024.
  • A 5-year average of $16166.7 and a median of -$34500.0 in 2022 frame the typical range for Change in Inventory.
  • On a YoY basis, Change in Inventory climbed as much as 255.43% in 2024 and fell as far as 287.96% in 2024.
  • Envoy Medical's Change in Inventory stood at -$32000.0 in 2022, then slumped by 187.5% to -$92000.0 in 2023, then surged by 255.43% to $143000.0 in 2024, then sank by 187.41% to -$125000.0 in 2025, then soared by 64.8% to -$44000.0 in 2026.
  • According to Business Quant data, Change in Inventory over the past three periods registered -$44000.0, -$125000.0, and $110000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 420.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 127.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 131.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 177.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 1.60 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -264.59 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 65.20 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 171.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -38.50 Mn
10 Envoy Medical - - -274,000.00 -44,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -44,000.00
Mar 31, 2026 -44,000.00
Dec 31, 2025 -125,000.00
Dec 31, 2025 -125,000.00
Sep 30, 2025 110,000.00
Sep 30, 2025 110,000.00
Jun 30, 2025 -37,000.00
Jun 30, 2025 -37,000.00
Mar 31, 2025 -74,000.00
Mar 31, 2025 -74,000.00
Dec 31, 2024 143,000.00
Dec 31, 2024 143,000.00
Sep 30, 2024 -203,000.00
Sep 30, 2024 -203,000.00
Jun 30, 2024 300,000.00
Jun 30, 2024 300,000.00
Mar 31, 2024 140,000.00
Mar 31, 2024 140,000.00
Dec 31, 2023 -92,000.00
Dec 31, 2023 -92,000.00
Sep 30, 2023 108,000.00
Sep 30, 2023 108,000.00
Dec 31, 2022 -32,000.00
Dec 31, 2022 -32,000.00